Ethic Inc. Abb Vie Inc. Transaction History

Ethic Inc.

$3.97 Billion
Q3 2024

A detailed history of Ethic Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Ethic Inc. holds 87,565 shares of ABBV stock, worth $16.9 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

87,565

Previous 94,679 7.51%

Holding current value

$16.9 Million

Previous $16.2 Million 6.48%

% of portfolio

0.44%

Previous 0.39%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $1.17 Million - $1.42 Million	-7,114 Reduced 7.51%	87,565 $17.3 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $1.1 Million - $1.29 Million	7,114 Added 8.12%	94,679 $16.2 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $7.83 Million - $8.92 Million	48,995 Added 127.03%	87,565 $15.9 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $491,782 - $553,862	3,574 Added 10.21%	38,570 $5.98 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $358,421 - $414,925	2,683 Added 8.3%	34,996 $5.22 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $515,198 - $641,131	-3,888 Reduced 10.74%	32,313 $4.35 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $79,824 - $91,930	-552 Reduced 1.5%	36,201 $5.77 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $2.17 Million - $2.61 Million	-15,719 Reduced 29.96%	36,753 $5.94 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $514,963 - $590,629	3,837 Added 7.89%	52,472 $7.04 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $2.31 Million - $2.93 Million	16,766 Added 52.61%	48,635 $7.45 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $1.61 Million - $1.99 Million	12,163 Added 61.72%	31,869 $5.17 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $81,109 - $102,627	755 Added 3.98%	19,706 $2.67 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $1.07 Million - $1.22 Million	10,064 Added 113.24%	18,951 $2.04 Million
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $365,183 - $406,835	-3,471 Reduced 28.09%	8,887 $1 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $410,836 - $452,281	-4,016 Reduced 24.53%	12,358 $1.34 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $246,299 - $332,530	-3,060 Reduced 15.75%	16,374 $1.75 Million
Q3 2020 Oct 27, 2020	BUY	$85.91 - $100.83 $375,770 - $441,030	4,374 Added 29.04%	19,434 $1.7 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $312,849 - $418,639	4,264 Added 39.5%	15,060 $1.48 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $49,020 - $74,320	760 Added 7.57%	10,796 $823,000
Q4 2019 May 22, 2020	BUY	$72.13 - $90.25 $90,811 - $113,624	1,259 Added 14.34%	10,036 $889,000
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $633,085 - $792,124	8,777 New	8,777 $777,000

Others Institutions Holding ABBV

# of Institutions

3,995

Shares Held

1.29B

Call Options Held

18.2M

Put Options Held

13.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account